Tempest Therapeutics, Inc. - FORM 10-K - EX-23.1 - March 16, 2015

Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - Tempest Therapeutics, Inc.Financial_Report.xls
EX-32.2 - EX-32.2 - Tempest Therapeutics, Inc.a2223498zex-32_2.htm
EX-21.1 - EX-21.1 - Tempest Therapeutics, Inc.a2223498zex-21_1.htm
EX-10.7 - EX-10.7 - Tempest Therapeutics, Inc.a2223498zex-10_7.htm
EX-32.1 - EX-32.1 - Tempest Therapeutics, Inc.a2223498zex-32_1.htm
EX-31.2 - EX-31.2 - Tempest Therapeutics, Inc.a2223498zex-31_2.htm
EX-31.1 - EX-31.1 - Tempest Therapeutics, Inc.a2223498zex-31_1.htm
EX-10.6 - EX-10.6 - Tempest Therapeutics, Inc.a2223498zex-10_6.htm
EX-10.33 - EX-10.33 - Tempest Therapeutics, Inc.a2223498zex-10_33.htm
EX-10.32 - EX-10.32 - Tempest Therapeutics, Inc.a2223498zex-10_32.htm
EX-10.24 - EX-10.24 - Tempest Therapeutics, Inc.a2223498zex-10_24.htm
EX-10.23 - EX-10.23 - Tempest Therapeutics, Inc.a2223498zex-10_23.htm
EX-10.21 - EX-10.21 - Tempest Therapeutics, Inc.a2223498zex-10_21.htm
EX-10.22 - EX-10.22 - Tempest Therapeutics, Inc.a2223498zex-10_22.htm
EX-10.34 - EX-10.34 - Tempest Therapeutics, Inc.a2223498zex-10_34.htm
10-K - 10-K - Tempest Therapeutics, Inc.a2223498z10-k.htm

QuickLinks -- Click here to rapidly navigate through this document


EXHIBIT 23.1

Consent of Independent Registered Public Accounting Firm

        We consent to the incorporation by reference in the Registration Statements (Form S-3 No. 333-183602, Form S-3 No. 333-187896, Form S-3 No. 333-190939, Form S-3 No. 333-200040, Form S-8 No. 333-182040, Form S-8 No. 333-187897 and Form S-8 No. 333-195780) of OvaScience, Inc. and in the related Prospectus of our report dated March 16, 2015, with respect to the consolidated financial statements of OvaScience, Inc., included in this Annual Report (Form 10-K) for the year ended December 31, 2014.

/s/ Ernst & Young LLP

Boston, Massachusetts
March 16, 2015



QuickLinks

Consent of Independent Registered Public Accounting Firm

Tempest Therapeutics, Inc. Reports